477 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 10 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABCA5ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5
Expressed in all
ABCB9ATP-binding cassette, sub-family B (MDR/TAP), member 9
VesiclesGlioma: 4.62e-4
Tissue enhancedtestis:23.9
ABCC9ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
Mixed
ABCD3ATP-binding cassette, sub-family D (ALD), member 3
PeroxisomesColorectal cancer: 1.16e-5
Renal cancer: 4.84e-5
Expressed in all
ABCD4ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ACKR1Atypical chemokine receptor 1 (Duffy blood group)
Cervical cancer: 2.52e-5
Liver cancer: 1.48e-4
Thyroid cancer: 9.76e-4
Mixed
ACKR2Atypical chemokine receptor 2
Nucleoplasm
Vesicles
Cytosol
Tissue enhancedplacenta:22.8
ACSL3Acyl-CoA synthetase long-chain family member 3
Nucleoli
Lipid droplets
Liver cancer: 2.75e-4
Lung cancer: 8.78e-4
Expressed in all
ACSL4Acyl-CoA synthetase long-chain family member 4
Golgi apparatus
Mitochondria
Urothelial cancer: 5.73e-4
Expressed in all
ACSL5Acyl-CoA synthetase long-chain family member 5
Nucleus
Mitochondria
Endometrial cancer: 1.13e-4
Expressed in all
ACSL6Acyl-CoA synthetase long-chain family member 6
Group enriched6bone marrow:18.0
cerebral cortex:62.1
parathyroid gland:22.1
seminal vesicle:28.7
testis:51.2
ADCYAP1R1Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
VesiclesEndometrial cancer: 5.78e-4
Tissue enhancedcerebral cortex:137.5
fallopian tube:46.5
ADGRD1Adhesion G protein-coupled receptor D1
Nucleus
Cytosol
Liver cancer: 9.27e-4
Tissue enhancedplacenta:44.3
ADGRL4Adhesion G protein-coupled receptor L4
Renal cancer: 1.60e-4
Mixed
ADORA1Adenosine A1 receptor
Plasma membraneTissue enhancedcerebral cortex:46.5
testis:23.4
AGPAT21-acylglycerol-3-phosphate O-acyltransferase 2
CentrosomeExpressed in all
AGTRAPAngiotensin II receptor-associated protein
VesiclesLiver cancer: 6.57e-7
Expressed in all
AIG1Androgen-induced 1
Golgi apparatusHead and neck cancer: 3.25e-7
Cervical cancer: 3.26e-6
Endometrial cancer: 3.06e-4
Expressed in all
ALDH3A2Aldehyde dehydrogenase 3 family, member A2
Renal cancer: 3.85e-8
Expressed in all
ALG12ALG12, alpha-1,6-mannosyltransferase
Endoplasmic reticulumRenal cancer: 3.60e-5
Endometrial cancer: 6.09e-4
Expressed in all
ALG8ALG8, alpha-1,3-glucosyltransferase
NucleoplasmExpressed in all
ALOX5APArachidonate 5-lipoxygenase-activating protein
Renal cancer: 5.68e-4
Ovarian cancer: 6.44e-4
Expressed in all
ANO10Anoctamin 10
Renal cancer: 6.41e-6
Endometrial cancer: 1.11e-4
Liver cancer: 3.19e-4
Colorectal cancer: 6.70e-4
Expressed in all
ANO2Anoctamin 2, calcium activated chloride channel
Nucleoplasm
Plasma membrane
Tissue enhancedtestis:17.7
ANO7Anoctamin 7
Tissue enhancedprostate:86.9
stomach:26.2
APH1AAPH1A gamma secretase subunit
Expressed in all
APOLD1Apolipoprotein L domain containing 1
Nucleoplasm
Cytosol
Tissue enhancedadipose tissue:142.0
AQP1Aquaporin 1 (Colton blood group)
Plasma membraneRenal cancer: 1.32e-8
Head and neck cancer: 6.52e-4
Expressed in all
AQP6Aquaporin 6, kidney specific
Tissue enriched9kidney:20.8
ARL6IP5ADP-ribosylation factor-like 6 interacting protein 5
Endoplasmic reticulumExpressed in all
ARL6IP6ADP-ribosylation factor-like 6 interacting protein 6
Nuclear membrane
Cytosol
Liver cancer: 1.73e-4
Renal cancer: 2.14e-4
Mixed
ARSEArylsulfatase E (chondrodysplasia punctata 1)
Golgi apparatusColorectal cancer: 8.95e-4
Tissue enhancedkidney:41.1
liver:49.1
ATL2Atlastin GTPase 2
Endometrial cancer: 4.51e-4
Expressed in all
ATP10AATPase, class V, type 10AN/A
Renal cancer: 6.60e-5
Mixed
ATP11CATPase, class VI, type 11C
Mixed
ATP13A2ATPase type 13A2
Liver cancer: 3.33e-7
Expressed in all
ATP13A3ATPase type 13A3
Nucleoli
Plasma membrane
Cytosol
Pancreatic cancer: 1.60e-4
Renal cancer: 1.63e-4
Expressed in all
ATP13A4ATPase type 13A4
NucleoplasmHead and neck cancer: 3.91e-4
Tissue enhancedepididymis:89.1
parathyroid gland:129.5
thyroid gland:68.2
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptide
Renal cancer: 8.98e-8
Liver cancer: 1.42e-4
Urothelial cancer: 4.01e-4
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1
Golgi apparatusLiver cancer: 5.06e-6
Pancreatic cancer: 1.52e-4
Renal cancer: 1.55e-4
Expressed in all
ATP6V0A2ATPase, H+ transporting, lysosomal V0 subunit a2
Plasma membrane
Cytosol
Expressed in all
ATP6V0BATPase, H+ transporting, lysosomal 21kDa, V0 subunit b
CytosolRenal cancer: 3.62e-6
Pancreatic cancer: 3.24e-4
Liver cancer: 4.79e-4
Urothelial cancer: 8.87e-4
Expressed in all
ATP6V0CATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
CytosolRenal cancer: 1.07e-6
Expressed in all
ATP9BATPase, class II, type 9B
Expressed in all
BCAP29B-cell receptor-associated protein 29
CytosolLiver cancer: 3.62e-4
Expressed in all
BCAP31B-cell receptor-associated protein 31
Endoplasmic reticulumHead and neck cancer: 9.87e-4
Expressed in all
BEST1Bestrophin 1
Mixed
BRI3BPBRI3 binding protein
Nucleoplasm
Mitochondria
Liver cancer: 6.87e-4
Mixed
BSCL2Berardinelli-Seip congenital lipodystrophy 2 (seipin)
Renal cancer: 7.55e-5
Expressed in all
BVESBlood vessel epicardial substance
Cell JunctionsTissue enhancedsmooth muscle:24.7

Page of 10 | next »